Capital Flow Monitor · Sponsors · CIK 1854270
Senti Biosciences Holdings, Inc.
2 Corporate Drive, First Floor, South San Francisco, CA, 94080 · 650-239-2030
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$40.0M
Sold
$10.0M
% sold
25.0%
Investors
1
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-06-04 | D ·current | 506(b) | $40.0M | $10.0M | 25.0% | 1 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Timothy Lu — Executive Officer / Director, South San Francisco, CA
-
Edward Mathers — Director, South San Francisco, CA
1 other raise
- Affinia Therapeutics Inc. $13.3M of $45.0M · 29.5%
- Frances D. Schulz — Director, South San Francisco, CA
- Donald Tang — Director, South San Francisco, CA
- Brenda Cooperstone — Director, South San Francisco, CA
- James J. Collins — Director, South San Francisco, CA
- Feng Hsiung — Director, South San Francisco, CA
-
Bryan Baum — Director, South San Francisco, CA
18 other raises
- SPIR II, LLC $5.0M of $5.0M · 100.0%
- K5 Tech Fund II LP - Series 210 $10.0M of $10.0M · 100.0%
- AJRX II, LLC $13.0M of $13.0M · 100.0%
- K5 Tech Fund II LP - Series 211 $5.0M of $5.0M · 100.0%
- K & Soda, Inc. $16.1M of $16.1M · 100.0%
- K5 Tech Fund II, LP - Series 206 $200.0M of $200.0M · 100.0%
- Khloud, Inc. $15.0M of $15.0M · 100.0%
- K5 Tech Fund II, LP - Series 203 $5.7M of $5.7M · 100.0%
- K5 Tech Fund I, LP - Ventures III-B $15.4M of $15.4M · 100.0%
- K5 Tech Fund II, LP - Series 204 $35.6M of $35.6M · 100.0%
- K5 HS HoldCo, LLC $365.9M of $365.9M · 100.0%
- K5 Tech Fund II, LP - Series 205 $8.0M of $9.0M · 88.6%
- K5 Tech Fund II, LP - Series 201 $10.0M of $10.0M · 100.0%
- K5 Tech Fund II, LP - Series 202 $3.0M of $5.0M · 60.0%
- Sprinter Spirits, Inc. $4.0M of $12.0M · 33.6%
- AJRX III, LLC $6.0M of $6.0M · 100.0%
- K5 Tech Fund I, LP - Series 109 $10.0M of $10.0M · 100.0%
- K5 Tech Fund I, LP - Series 116 $7.0M of $7.0M · 100.0%
- Jay Cross — Executive Officer, South San Francisco, CA
- Kanya Rajangam — Executive Officer, South San Francisco, CA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.